(Q35197824)

7 August 2017

1 reference

title

Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone (English)

1 reference

7 August 2017

Luc F Van Gaal

1

1 reference

PubMed ID

12914718

7 August 2017

Ilse L Mertens

series ordinal

2

1 reference

PubMed ID

12914718

7 August 2017

Pascale J Abrams

series ordinal

3

1 reference

7 August 2017

1 August 2003

1 reference

Growth Hormone & I G F Research

7 August 2017

1 reference

7 August 2017

13 Suppl A

1 reference

7 August 2017

S4-9

1 reference

The worldwide obesity epidemic

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Do elevated levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concentrations in men?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Visceral obesity and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Abdominal adiposity and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Treatment of obesity: need to focus on high risk abdominally obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Obesity, haemostasis and the fibrinolytic system

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Life without white fat: a transgenic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

An undiagnosed endocrinometabolic syndrome: report of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

The IGF-I/IGFBP system in congenital partial lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Syndrome of body fat redistribution in HIV-1-infected patients: relationships to cortisol and catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Clinical endocrinology of human leptin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Human leptin: from an adipocyte hormone to an endocrine mediator

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Serum leptin levels in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Lipodystrophy in MCGN type II: the clue to links between the adipocyte and the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Leptin-replacement therapy for lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Leptin: a novel therapeutic role in lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Use of growth hormone and other anabolic agents in AIDS wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900046-7

7 January 2021

10.1016/S1096-6374(03)00046-7

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12914718